Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 6 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $33.00 (40.13% upside)

Analysts' Ratings History for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/30/2014ZacksReiterated RatingNeutral -> Neutral$29.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014ZacksUpgradeUnderperform -> Neutral$26.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
3/31/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Credit SuisseDowngradeOutperform -> Neutral$45.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
2/4/2014ZacksDowngradeNeutral -> Underperform$32.00ViewTweet This Rating  Share This Rating on StockTwits
12/5/2013RBC CapitalBoost Price TargetOutperform$41.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
11/28/2013ZacksReiterated RatingNeutral -> Neutral$38.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2013Leerink SwannReiterated RatingOutperform$40.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2013ZacksReiterated RatingNeutral -> Neutral$36.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2013Bank of AmericaUpgradeNeutral -> Buy$36.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2013RBC CapitalBoost Price TargetOutperform$41.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013ZacksReiterated RatingNeutral -> Neutral$31.00ViewTweet This Rating  Share This Rating on StockTwits
7/16/2013Credit SuisseLower Price TargetOutperform$38.00 -> $37.00ViewTweet This Rating  Share This Rating on StockTwits
7/12/2013RBC CapitalReiterated RatingOutperform$41.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2013ZacksReiterated RatingNeutral -> Neutral$35.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
6/5/2013Piper JaffrayInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
4/29/2013ZacksReiterated RatingNeutral -> Neutral$35.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2013Jefferies GroupBoost Price TargetBuy$36.00 -> $38.50ViewTweet This Rating  Share This Rating on StockTwits
3/27/2013GuggenheimInitiated CoverageMarket Perform -> Buy$39.00ViewTweet This Rating  Share This Rating on StockTwits
3/15/2013Credit SuisseInitiated CoverageOutperform$38.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2013ZacksReiterated RatingNeutral -> Neutral$33.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013RBC CapitalBoost Price TargetOutperform$38.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Bank of AmericaReiterated RatingNeutral$33.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013WallachBeth CapitalBoost Price TargetBuy$30.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013Leerink SwannBoost Price Target$34.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013Jefferies GroupBoost Price TargetBuy$34.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013Jefferies GroupBoost Price Target$34.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013WallachBeth CapitalBoost Price TargetBuy$30.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
2/5/2013RBC CapitalBoost Price TargetOutperform$34.00 -> $37.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2013Bank of AmericaReiterated RatingNeutral$26.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2013Leerink SwannBoost Price TargetOutperform$34.00 -> $37.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013ISI GroupInitiated CoverageBuy$30.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012ZacksReiterated RatingNeutral -> Neutral$23.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012Leerink SwannBoost Price TargetOutperform$30.00 -> $34.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012JPMorgan Chase & Co.UpgradeNeutral -> Overweight$28.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2012Leerink SwannReiterated RatingOutperform$28.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2012OppenheimerInitiated CoverageOutperform$35.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2012Credit SuisseInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/26/2012ZacksReiterated RatingNeutral -> Neutral$24.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2012Citigroup Inc.Initiated CoverageNeutral$27.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2012Jefferies GroupUpgradeHold -> Buy$34.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2012ZacksDowngradeOutperform -> Neutral$25.00ViewTweet This Rating  Share This Rating on StockTwits
8/22/2012Bank of AmericaInitiated CoverageNeutral$29.00ViewTweet This Rating  Share This Rating on StockTwits
8/17/2012ZacksUpgradeNeutral -> Outperform$30.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)